COMPANY
BioStem Technologies
Funding and NIH signals
- SEC Form D raise Raised $3M (Form D filed Oct 9, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0001213900-26-108470 (Oct 9, 2026)
Evidence (2 events)
- Oct 9, 2026 · SEC Form D 0001213900-26-108470
Name of Issuer: BioStem Technologies, Inc.; CIK: 1658678; Address: Pompano Beach, FL; Submission type: D; Filing date: 2026-10-09; Industry Group: Biotechnology; Date of First Sale: 2026-09-29; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 3000000; Federal exemptions: 06b - Sep 21, 2026 · SEC Form D 0001213900-26-101819
Name of Issuer: BioStem Technologies, Inc.; CIK: 1658678; Address: Pompano Beach, FL; Submission type: D; Filing date: 2026-09-21; Industry Group: Biotechnology; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 40000000; Total Amount Sold: 0; Federal exemptions: 06b
- Oct 9, 2026 · SEC Form D 0001213900-26-108470
Timeline
- Raise Private placement: $2.5M (total, as published), announced May 22, 2026. Source: company release on GlobeNewswire. source ↗ · Form D filed Jun 3, 2026 SEC Form D ↗
Funding
- Private placement: $2.5M (total, as published), announced May 22, 2026. Source: company release on GlobeNewswire. source ↗ · Form D filed Jun 3, 2026 SEC Form D ↗